Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a ...

NervGen Pharma (TSE:NGEN) has released an update. NervGen Pharma, a clinical-stage biotech company, is set to present at the Stifel 2024 ...

Target enrollment in the chronic cohort close to completionVancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In the last year, drugmakers have talked up the prospect of medicines discovered or designed by artificial intelligence. AI could accelerate the pace of new drugs approved to treat everything from ...

The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use one or multiple different selling models. However, how many pharma executives ...

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative ...

As of 08:04 CET. Market open. Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to ...

Featured here, the Balance Sheet for NervGen Pharma Corp, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...